Market Bizzz

The 200-day DMA is used as a key indicator by traders for determining the overall trend in a particular stock. As long as the stock is priced above the 200-day SMA on the daily time frame, it is generally considered to be an overall uptrend.

Smartworks will launch its IPO on July 10 to raise Rs 445 crore via fresh issue and OFS. The company operates over 10 million sq ft of flexible workspace.

Rajesh Palviya of Axis Securities sees bullish momentum continuing as Nifty holds above key support. Pharma, oil & gas, and capital goods are showing strong breakouts. Glenmark and Reliance are top picks. Meanwhile, Trent may consolidate between Rs 5,000–Rs 6,000, offering a potential buy on dips opportunity for long-term investors.

Smarten Power System’s Rs 50 crore SME IPO opens on July 7, with shares priced at Rs 100 each. The issue includes fresh equity and offer for sale, and will list on NSE SME platform on July 14.

According to exchange data, Bajaj Finance offloaded 3.09 lakh shares at Rs 196.32 apiece, totalling Rs 61 crore. Motilal Oswal Mutual Fund sold 2.7 lakh shares at Rs 211.14, fetching Rs 57.04 crore, while HRTI Private Limited exited 2.61 lakh shares at Rs 196.48, amounting to Rs 51.37 crore.

Sebi Probe: Sebi’s probe into Jane Street may expand beyond Nifty options to include trades on other indices and exchanges. While the investigation could take time, it is unlikely to trigger broad market disruption, an ET Now report stated. Retail F&O participation has eased, but nearly 90% of traders still continue to incur losses.

Investec Capital Services’ Mukul Kochhar highlights India’s strong underlying market strength, anticipating double-digit earnings growth for BSE 500 companies. While responsible fiscal management and lower inflation support valuations, securing trade treaties remains crucial for integrating into global supply chains. Kochhar favors domestic cyclicals, financials, industrials, and auto sectors, while expressing caution towards consumer staples and IT services.

BC Investments IV, linked to Bain Capital, is expected to sell a 2.4% stake in Emcure Pharmaceuticals. The sale will occur through a block deal valued at Rs 551 crore. About 45.5 lakh shares will be sold at Rs 1,279.80 each. Kotak Securities is managing the deal. Emcure’s stock is currently below its all-time high despite strong quarterly results.

A Balasubramanian of ABSL AMC highlights the growth potential of India’s insurance sector, particularly life insurance, driven by increased focus and new product offerings. Despite current economic slowdown indicators like reduced credit offtake and GST dips, he remains optimistic. He anticipates market growth due to proactive measures by the Reserve Bank of India and a forward-looking market perspective.